Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

12.22
Delayed Data
As of Jul 31
 +0.20 / +1.66%
Today’s Change
8.00
Today|||52-Week Range
27.33
-25.80%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close12.02
Today’s open12.04
Day’s range11.73 - 12.51
Volume62,286
Average volume (3 months)221,137
Market cap$251.5M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+99.58%
Earnings growth (this year)-31.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
TBRATobira Therapeutics ...+0.73+5.36%
NVLSNivalis Therapeutics...-0.43-2.47%
PPHMPeregrine Pharmaceut...-0.02-1.60%
ASMBAssembly Biosciences...-0.06-0.40%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$0.00
Annual profit (last year)-$47.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior VP-Operations &
Product Strategy
Theodore T. Ashburn
Corporate headquarters
Cambridge, Massachusetts

Forecasts